OxCODE travel awards 2025
25 June 2025
Congratulations to Zinaida Dedeic, Joshua Fieggen, Ella Mi, Shizhe Xu, Yuhan Zheng and Noushin Zibandeh who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
OxCODE funding scheme awards 2025
11 June 2025
Congratulations to Adam Creamer, Pengfei Li, Francisco Lopez-Cuevas, Yuqi Shen and their collaborators who have been awarded funding in the sixth round of the OxCODE Funding Scheme.
New algorithms can help GPs predict which of their patients have undiagnosed cancer
12 May 2025
The algorithms use information about a person’s health conditions and simple blood tests to accurately predict a patient’s chances of having a currently undiagnosed cancer.
New guidelines published for monitoring IBD patients to prevent bowel cancer
4 May 2025
Researchers and clinicians the Universities of Oxford, Newcastle and Central Lancashire and others have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
CRUK funding for research into earlier detection of relapse in people with multiple myeloma
9 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
Daily physical activity, even at light intensities, linked to lower cancer risk
28 March 2025
A study led by Oxford researchers has found that the number of steps taken daily may be more important for lowering cancer risk than the intensity of activity.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
25 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
New biopsy technique found to improve prostate cancer detection
25 March 2025
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Dr Parinaz Mehdipour awarded CRUK Early Detection and Diagnosis Primer Award
4 March 2025
The funded research aims to identify circular RNA biomarkers for the early detection of normal colon cell transformation into precancerous and colorectal cancer states.
Bowel cancer prediction test for IBD patients 90% accurate
4 February 2025
OxCODE researchers have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 January 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Increased calcium and dairy intake lower risk of bowel cancer by nearly a fifth
8 January 2025
In the largest study to date into the link between diet and bowel cancer, Oxford researchers have found that an additional 300mg of calcium each day is associated with a 17% decrease in the risk of colorectal cancers.
Oxford researchers develop blood test to enable early detection of multiple cancers
8 January 2025
Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 January 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
8 November 2024
Research from Professor Julia Hippisley-Cox shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas, with important implications for NHS screening.
OxCODE researchers at the Early Detection of Cancer Conference 2024
25 October 2024
Oxford’s early detection research was featured at this annual event.
Oxford Liver Cancer Centre of Excellence (OLivE) launched
24 October 2024
Oxford Cancer announces the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
OxCODE funding scheme awards 2024
22 October 2024
Congratulations to I-Jun Lau, Dimitris Vavoulis and their collaborators who have been awarded funding in the fifth round of the OxCODE Funding Scheme.